KISSEI PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,230 JPY | +0.94% |
|
+0.16% | +4.53% |
| Jun. 10 | Kissei Pharmaceutical Licenses Linzagolix to JW Pharmaceutical for Korean Market | MT |
| Jun. 10 | Kissei Pharmaceutical Co., Ltd. Enters into License Agreement with Jw Pharmaceutical Corporation | CI |
Chart calendar Kissei Pharmaceutical Co., Ltd.
3d7042c7b1216732475161cba3c574.HW6z6wTDtYr9KmCJn6Aqpfy01yAK1tv0QR5F9r7p4yA.fyCE0lGhh_uyeRbD2ZdG8KnFk2delbO3ECktk4-51RR1MdSpM6_GwYVAIQ~3b9ad1681314a6a464d4f488823ad7fb
Upcoming events on Kissei Pharmaceutical Co., Ltd.
Past events on Kissei Pharmaceutical Co., Ltd.
| 2024-06-24 09:00 pm | Annual General Meeting |
| 2024-05-08 | Q4 2023 Earnings Call |
| 2024-05-06 | Q4 2023 Earnings Release |
| 2024-03-27 | Final dividend |
| 2024-01-29 | Q3 2023 Earnings Release |
| 2023-11-05 | Q2 2023 Earnings Release |
| 2023-09-27 | Détachement de for dividende intermédiaire |
| 2023-07-30 | Q1 2023 Earnings Release |
| 2023-06-21 09:00 pm | Annual General Meeting |
| 2023-05-07 | Q4 2022 Earnings Release |
| 2023-03-29 | Détachement de for final dividend |
| 2023-01-30 | Q3 2022 Earnings Release |
| 2022-11-07 | Interim 2022 Earnings Call |
| 2022-11-07 | Interim 2022 Earnings Release |
| 2022-09-28 | Détachement de for dividende intermédiaire |
| 2022-07-31 | Q1 2022 Earnings Release |
| 2022-05-09 | FY 2021 Earnings Call |
| 2022-05-09 | FY 2021 Earnings Release |
| 2022-03-29 | Détachement de for final dividend |
| 2022-01-31 | Q3 2021 Earnings Call |
Past dividends on Kissei Pharmaceutical Co., Ltd.
| 2024-03-27 | Final Payment 41 JPY |
| 2023-09-27 | Interim Payment 41 JPY |
| 2023-03-29 | Final Payment 40 JPY |
| 2022-09-28 | Interim Payment 40 JPY |
| 2022-03-29 | Final Payment 28 JPY |
| 2021-09-28 | Interim Payment 28 JPY |
| 2021-03-29 | Final Payment 27 JPY |
| 2020-09-28 | Interim Payment 27 JPY |
| 2020-03-29 | Final Payment 26 JPY |
| 2019-09-26 | Interim Payment 26 JPY |
Annual results
| Fiscal Period | March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 63 234 61 700 2.49% | 69 044 67 600 2.14% | 65 381 66 000 -0.94% | 67 493 68 700 -1.76% | 75 579 77 267 -2.18% | 82 150 |
|
EBITDA Million JPY | Released Forecast Spread | 0,00 0,00 - | 4 653 9 377 -50.38% | 0,00 0,00 - | 0,00 0,00 - | 17 401 17 285 0.67% | 15 265 |
|
EBIT Million JPY | Released Forecast Spread | 1 857 2 450 -24.2% | 1 505 750 100.67% | -1 402 -1 700 17.53% | -1 129 500 -325.8% | 4 017 5 767 -30.34% | 5 250 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 4 630 5 350 -13.46% | 7 476 6 050 23.57% | 16 507 4 700 251.21% | 13 680 14 100 -2.98% | 14 449 15 093 -4.27% | 16 140 |
|
Net income Million JPY | Released Forecast Spread | 2 817 3 850 -26.83% | 5 285 4 550 16.15% | 12 921 3 400 280.03% | 10 528 10 800 -2.52% | 11 160 11 433 -2.39% | 12 300 |
|
EPS JPY | Released Forecast Spread | 60,3 82,4 -26.81% | 113 97,6 16.03% | 280 72,9 284.36% | 228 234 -2.51% | 247 244 1.02% | 278 |
| Announcement Date | 12/05/20 | 11/05/21 | 10/05/22 | 08/05/23 | 07/05/24 | - |
Quarterly results
| Fiscal Period | March | 2021 S1 | 2022 S1 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 S1 | 2026 Q1 | 2026 S1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 32 284 31 200 3.47% | 32 388 32 200 0.58% | 16 285 15 650 4.06% | 16 579 15 450 7.31% | 32 864 31 225 5.25% | 18 771 | 19 313 17 750 8.81% | 36 978 36 800 0.48% | 20 881 | 19 800 | 41 700 | 21 000 | 41 800 | ||
|
EBIT Million JPY | Released Forecast Spread | 2 044 700 192% | 270 -600 145% | 130 50,0 160% | -755 -300 -151.67% | -625 -50,0 -1150% | 1 117 | 1 633 700 133.29% | 2 015 2 000 0.75% | 2 149 | 600 | 2 800 | 1 800 | 3 000 | ||
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 5 711 | 7 273 6 373 14.12% | 2 141 2 700 -20.7% | 2 277 1 500 51.8% | 4 418 4 200 5.19% | 4 572 | 4 349 3 400 27.91% | 7 502 | 3 598 | ||||||
|
Net income Million JPY | Released Forecast Spread | 4 396 1 600 174.75% | 5 666 5 100 11.1% | 1 635 2 040 -19.85% | 1 691 1 090 55.14% | 3 326 3 585 -7.22% | 3 341 | 3 265 2 288 42.7% | 5 678 5 900 -3.76% | 2 659 | 2 500 | 6 500 | 3 400 | 6 600 | ||
|
EPS JPY | Released Forecast Spread | 94,1 34,2 175.2% | 123 93,3 31.69% | 35,5 44,3 -19.84% | 36,7 24,0 52.75% | 72,1 78,0 -7.47% | 72,5 | 71,0 49,7 42.76% | 52,7 51,4 2.53% | 124 131 -5.46% | 59,2 | 63,7 | 56,6 | 147 | 76,9 | 149 |
| Announcement Date | 05/11/20 | 09/11/21 | 01/08/22 | 08/11/22 | 08/11/22 | 31/01/23 | 31/07/23 | 06/11/23 | 06/11/23 | 30/01/24 | 07/05/24 | - | - | - | - |
More events
Past sector events for Kissei Pharmaceutical Co., Ltd.
| 2024-05-23 01:00 am | CALLIDITAS THERAPEUTICS AB: Q1 2024 Earnings Release |
| 2024-05-15 01:00 am | MERCK KGAA: Q1 2024 Earnings Release |
| 2024-05-13 | OSCOTEC INC.: Q1 2024 Earnings Release |
| 2024-05-13 | MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release |
| 2024-05-08 | SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-08 04:05 pm | SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-06 | KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-06 | KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release |
| 2024-04-29 | YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-29 | HK INNO.N CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4547 Stock
- Calendar Kissei Pharmaceutical Co., Ltd.
